Capecitabine-oxaliplatin (CAPOX) prior to chemoradiotherapy (CRT) and surgery in magnetic resonance imaging (MRI)-defined poor-risk rectal carcinoma (PRRC): A center experience.
Isabel Busquier(Fundación Hospital Provincial de Castellón), Jorge Molina(Fundación Hospital Provincial de Castellón), V. Morillo(Fundación Hospital Provincial de Castellón), Leticia De avila, Carlos Burriel(Fundación Hospital Provincial de Castellón), María De Julián, María José Domper-Arnal(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Jorge Soler(Fundación Hospital Provincial de Castellón), Nuria Gutiérrez Ruiz(Fundación Hospital Provincial de Castellón)
Cited by 0
Related Papers
Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries
|World Journal of Gastroenterology|2015|1k
Gastrointestinal and cardiovascular adverse events associated with NSAIDs
|Expert Opinion on Drug Safety|2021|134
The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients
|Therapeutic Advances in Gastroenterology|2022|21